Receive our newsletter – data, insights and analysis delivered to you
  1. News
April 4, 2016

TE Connectivity buys Creganna for $895m

Swiss designer and manufacturer of connectivity and sensor solutions TE Connectivity has completed the acquisition of Ireland's Creganna Medical Group for $895m.

Swiss designer and manufacturer of connectivity and sensor solutions TE Connectivity has completed the acquisition of Ireland’s Creganna Medical Group for $895m.

The companies entered into a definitive agreement regarding this deal in February this year.

Creganna designs and manufactures minimally invasive delivery and access devices, which can be used in a wide range of therapies.

"Combining Creganna with TE’s existing medical business establishes TE as a leader in the attractive minimally-invasive interventional segment of the medical device market."

The Irish company provides services to medical device original equipment manufacturers (OEMs) in around 30 countries worldwide.

Creganna’s customers include around 400 companies, comprising medical device and life science firms, while it has design and manufacturing facilities in the US, South America, Europe and Asia.

Last year, the company had reported sales of around $250m.

Content from our partners
“Everything is custom”: Behind the scenes of medical wire solutions
The added value of Qarad’s multilingual freephone service to their eIFU solution
Small and simple: how medical device manufacturers select materials

TE Connectivity chairman and CEO Tom Lynch said: "Creganna’s products are used in life-saving medical treatments and surgical procedures where the highest levels of quality, reliability and performance are essential.

"Combining Creganna with TE’s existing medical business establishes TE as a leader in the attractive minimally-invasive interventional segment of the medical device market.

"TE now has the most complete product and capability offering in the industry, and is a fully integrated strategic supplier to major OEMs."

The acquired business section of Creganna will be inducted as a part of TE’s industrial solutions segment.

TE’s existing manpower of 7,000 product development engineers assigned to the medical segment will gain more than 225 product development engineers after the acquisition.

TE’s adjusted earnings per share is expected to be augmented by $0.03 in the first full fiscal year and will subsequently boost TE’s revenue growth and earnings before interest, taxes, depreciation and amortisation margins.

Morgan Stanley served as TE’s financial advisor and the outside counsel was Davis Polk and Wardwell during the acquisition.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU